Skip to the page

Data / Form D filings / Dignify Therapeutics, LLC

Dignify Therapeutics, LLC: Form D filings

Dignify Therapeutics, LLC, a pharmaceuticals company in Research Triangle Park, NC, filed 3 Form D notices with the SEC between 2014 and 2026. The latest, on September 25, 2026, reports $800,000 sold of a $3 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2 DAVIS DRIVE, Research Triangle Park, NC, 27709
Phone
(919) 491-0369
Industry
Pharmaceuticals
Entity type
Limited Liability Company
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1622906

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 25, 2026New notice$3,000,000$800,000$2,200,0002Sep 15, 2026sec.gov
Feb 25, 2015Amendment$3,445,868$3,445,8687Oct 10, 2014sec.gov
Oct 24, 2014New notice$3,000,000$99,997$2,900,0031Oct 10, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Anthony DiTonnoExecutive Officer, Director
Edward C. BurgardDirector
Eric GreenDirector
Karl B. ThorDirector
Neil KurtzDirector
Howard PalefskyDirector

Every Form D from the week of Sep 21, 2026 · All recent filings in North Carolina · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Dignify Therapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.